Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Exagen Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 54 | 1 | 53 | 0 |
| Shares | 8.61M | 958 | 8.78M | +168.9K (+2.0%) |
| Value | $129.2M | $14.0K | $119.6M | −$9.58M (−7.4%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Exagen Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen Prime Advisors LLC | 182,900 | $2.49M | 0.93% |
| Natixis | 125,000 | $1.70M | 0.01% |
| Penbrook Management LLC | 87,750 | $1.19M | 0.75% |
| Total Clarity Wealth Management, Inc. | 1,565 | $21.0K | 0.01% |
| First Horizon Advisors, Inc. | 1,214 | $17.0K | 0.00% |
Sold out (5)
Institutions that held Exagen Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Nomura Holdings Inc | 355,000 | $5.33M |
| Bank of Montreal | 236,000 | $3.55M |
| Pura Vida Investments, LLC | 51,502 | $772.0K |
| Victory Capital Management Inc | 36,345 | $545.0K |
| Walleye Capital LLC | 12,398 | $186.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Exagen Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Horizon Corp | 958 | $14.0K |